Since the 1980s, the number of studies on the physiology of erectile function and the pathophysiology of erectile dysfunction (ED) has grown substantially. The risk of mistakes in research techniques has accompanied this growth. This review discusses common mistakes to help other scientists and researchers, especially those who are new to the field.
Definitions and terminology for female sexual arousal disorder (FSAD) are currently being debated. While some authors have suggested that FSAD is more a subjective response rather than a genital response, others have suggested that desire and arousal disorders should be combined in one entity. Persistent genital arousal disorder (PGAD) is a new entity which is suggested to be defined as Restless Genital Syndrome.
Many factors can influence men’s erectile function (EF) after seed brachytherapy, Australian and British researchers have reported.
Researchers have found a high prevalence of chronic periodontitis (CP) in patients with erectile dysfunction (ED) and a strong relationship between the two conditions. However, it is not known how the severity and type of CP affects erectile function. This case-controlled study looked at the relationship between the severity of ED and CP and the correlation between clinical periodontal parameters and ED.
New research on urinary and sexual outcomes could eventually help prostate cancer patients decide on their course of treatment.
The drug flibanserin is currently in clinical trials for the treatment of HSDD and is showing some encouraging results in premenopausal women, including improved sexual desire and an increase in the number of satisfying sexual events. The current study aimed to investigate how acute and chronic doses of flibanserin affected sexual behavior in ovariectomized (OVX) female rats who have been primed with either a combination of estradiol benzoate (EB) and progesterone (P) [Experiment 1] or estradiol benzoate (EB) alone [Experiment 2].